TABLE 2.
Post-index Antihyperlipidemic Medication Classification in the Subgroup of the Antihyperlipidemic Treatment Patterns Cohort Matched on Pre-index Classification in a Post Hoc Analysis (N = 1,526)
| Overall (N = 1,526) | Guideline (n = 763) | Historical (n = 763) | P Valuea | ||||
|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | ||
| Antihyperlipidemic medication classification | |||||||
| None | 386 | 25.3 | 193 | 25.3 | 193 | 25.3 | < 0.001 |
| Nonstatin medication | 152 | 10.0 | 53 | 6.9 | 99 | 13.0 | |
| Low-intensity statin | 24 | 1.6 | 14 | 1.8 | 10 | 1.3 | |
| Moderate-intensity statin | 659 | 43.2 | 322 | 42.2 | 337 | 44.2 | |
| High-intensity statin | 305 | 20.0 | 181 | 23.7 | 124 | 16.3 | |
a Post-index medication classifications compared for matched pairs using Stuart-Maxwell test.